Disease
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 8, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a recruiting observational registry study with no reported results; it represents planned diagnostic evaluation in a disease area, not yet generating evidence on clinical utility or accuracy.
This is a recruiting observational study with no results posted; it represents planned work in an early phase that will require completion and analysis before evidence can be judged.
AUG 10, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a registry record for a planned retrospective observational study with no results reported; it describes methodology and enrollment targets only.
JUN 30, 2026 · JOURNAL ARTICLE
Gut Microbes
This is a narrative review synthesizing mechanistic and observational evidence about F. nucleatum's role in systemic disease, raising questions about causality and therapeutic targets rather than reporting new empirical data or clinical trials.
FEB 6, 2026 · JOURNAL ARTICLE
Dialogues in Clinical Neuroscience
This is a narrative literature review synthesizing current evidence on biomarkers for neurodegenerative diseases without presenting primary data or meta-analytic findings.
JAN 23, 2026 · JOURNAL ARTICLE
Annals of Medicine
This is a narrative review synthesizing heterogeneous preclinical and mechanistic evidence across multiple organ systems without meta-analysis, original clinical trials, or definitive human efficacy data to support GPR3 as a therapeutic target.